Related Experiment Videos
Blood transfusion and tumour growth: an experimental study
The Australian and New Zealand Journal of Surgery
|October 1, 1985
Summary
Blood transfusions, both allogeneic and syngeneic, prolonged survival in a mouse model of mammary tumors. Syngeneic blood showed the greatest survival benefit, suggesting general beneficial effects rather than specific immunological responses.
Area of Science:
- Oncology
- Immunology
- Transfusion Medicine
Background:
- RIII mice spontaneously develop mammary tumors, providing a relevant model for cancer research.
- Understanding factors influencing tumor growth and survival is crucial for developing effective cancer therapies.
Purpose of the Study:
- To investigate the impact of allogeneic and syngeneic blood transfusions on mammary tumor growth and survival in RIII mice.
- To differentiate between general physiological effects and specific immunological responses of blood transfusion on tumor progression.
Main Methods:
- RIII mice received blood transfusions from C57b1 mice (allogeneic) or syngeneic blood.
- Transfusions were administered either before tumor cell inoculation or both before and after inoculation.
- Control groups received saline infusions.
- Survival rates were compared across different transfusion protocols.
Main Results:
- Allogeneic transfusion before tumor inoculation did not significantly alter survival compared to syngeneic transfusion.
- Both allogeneic and syngeneic blood transfusions administered before and after tumor inoculation prolonged survival compared to saline infusion.
- Syngeneic blood transfusion resulted in the longest survival duration.
Conclusions:
- Blood transfusion, particularly syngeneic, can enhance survival in a mouse model of mammary tumors.
- The observed survival benefit is likely due to general beneficial effects of blood transfusion, not specific immune-mediated mechanisms.
- Further research into the physiological mechanisms underlying transfusion benefits in cancer models is warranted.